Loading...

CANCER MARKER PROFILE BRAIN & PITUITARY

image not found

NABL Cap Accredited 
The Brain & Pituitary Cancer Marker Profile at Metropolis Healthcare evaluates specific tumor markers in blood to help detect and monitor brain or pituitary tumors. This panel supports early detection, treatment monitoring, and clinical decision-making. Metropolis ensures accurate results through advanced immunoassays and expert oncological interpretation.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 3,655.00

Sample Type: Serum

Fasting Not Requierd


Booking Procedure:
  1. Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
  2. Sample will be collected by our technician at your address at given slot.
  3. You can make the payment to the technician at the time of collection
  4. Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
  5. Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.

Frequently Asked Questions (FAQ's):

What is included in the Brain & Pituitary Cancer Marker Profile?
It typically measures tumor markers relevant to brain and pituitary tumors, aiding early detection and monitoring.

Who should consider this test?
Patients with neurological symptoms, pituitary disorders, family history of tumors, or those under treatment for brain or pituitary tumors.

How is the sample collected?
A blood sample is collected at Metropolis Healthcare for tumor marker analysis.

Is fasting required for this test?
No fasting is necessary. The test can be performed without special preparation.

How accurate are the results from Metropolis Healthcare?
Metropolis ensures high accuracy using advanced immunoassay platforms, expert technicians, and strict quality protocols.

Can this test diagnose brain or pituitary cancer on its own?
No, it is a supportive tool. Diagnosis requires imaging studies, clinical evaluation, and additional tests.

How often should this test be done?
Frequency depends on individual risk, treatment monitoring, and doctor’s recommendations.

How does this test help in treatment planning?
It aids in monitoring therapy response, detecting recurrence early, and guiding clinical decisions for patient management.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab